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Free l‑glutamate‑induced
modulation in oxidative
and neurochemical profile
contributes to enhancement
in locomotor and memory
performance in male rats
Saiqa Tabassum1,2, Saara Ahmad3, Syeda Madiha1, Sidrah Shahzad1, Zehra Batool4,
Sadia Sadir1 & Saida Haider1*
Glutamate (Glu), the key excitatory neurotransmitter in the central nervous system, is considered
essential for brain functioning and has a vital role in learning and memory formation. Earlier it was
considered as a harmful agent but later found to be useful for many body functions. However, studies
regarding the effects of free l-Glu administration on CNS function are limited. Therefore, current
experiment is aimed to monitor the neurobiological effects of free l-Glu in male rats. l-Glu was orally
administered to rats for 5-weeks and changes in behavioral performance were monitored. Thereafter,
brain and hippocampus were collected for oxidative and neurochemical analysis. Results showed that
chronic supplementation of free l-Glu enhanced locomotor performance and cognitive function of
animals which may be attributed to the improved antioxidant status and cholinergic, monoaminergic
and glutamatergic neurotransmission in brain and hippocampus. Current results showed that chronic
supplementation of l-Glu affects the animal behaviour and brain functioning via improving the
neurochemical and redox system of brain. Free l-Glu could be a useful therapeutic agent to combat
neurological disturbances however this requires further targeted studies.
Central nervous system (CNS) modulates behaviour and brain functioning with the help of multiple neurotransmitters. One of the important neurotransmitters is Glutamate (Glu)1 which is a nonessential amino acid (AA)
present abundantly in the body2. It is involved in a variety of body functions either directly or by converting into
other products3. Evidence shows the importance of Glu in facilitating protein synthesis4, intestinal nutrition, cell
signalling, gene expression modulation, immune r esponses5, regulating blood glucose level, removing excess
ammonia6, disposal of excess or waste n
 itrogen7 as well as in intermediary m
 etabolism2 as an important energy
fuel5. Other than this, it is also a precursor of various biologically active components like glutathione (GSH),
GABA, purine and pyrimidine nucleotides, polyamines, poly-glutamated folate cofactors or certain AAs like
glutamine, alanine, aspartate, proline, arginine, c itrulline2–5,8. Glu is present in various foods either as naturally
occurring free Glu (vegetable, seafood, milk, meat, cheese) or as a by-product of hydrolysed protein (used in
seasoning) or as a salt; MSG (monosodium glutamate), a food additive or flavouring agent in canned foods, dry
mixes, sauces, and s oups9.
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Figure 1.  Schematic representation of treatment schedule and experimental design.

Nutritionally, Glu is important for taste perception and for facilitation of gastric and pancreatic f unction3,9.
Various studies have reported the potential health effects of dietary glutamate supplementation that include
improvement of taste and palatability10, modification of gastric secretion and motility, enhanced cellular
proliferation11, stimulation of gastro-intestinal exocrine secretions and prevention of incidence of d
 iarrhoea12.
It is also used to treat d
 yspepsia13, improves growth performance, enhances protein s ynthesis4,14, restores
mucous circulation and AA metabolism, and prevents cellular injury and apoptosis of enterocytes4. Reports
have also shown its potential in amelioration of endotoxin-induced intestinal damage and maintaining intestinal
integrity5,14, increasing nucleotide s ynthesis3, improving antioxidant status15, ROS scavenging16, amelioration of
hypoxia-induced oxidative s tress17, inhibition of fat a ccumulation18 and progression of atherogenesis and fatty
liver disease19.
Glu metabolism is shown to be mainly involved in maintaining normal brain function20 to regulate neurogenesis, synaptogenesis, neurite outgrowth and neuronal s urvival21. Most of the brain Glu is synthesised either
from glucose or 3-hydroxybutyrate or from other AAs8. High concentration of Glu is present in blood and CSF22
and in brain regions responsible for mediating memory and cognitive functioning like cortex, hippocampus and
striatum1,23. Synaptic Glu signalling is involved in neuronal growth and synaptic p
 lasticity24 contributing to learning and memory processing and cognitive functioning1,2,25,26. Its usefulness in facilitation of potassium transport
across blood brain barrier (BBB) suggests its promising role in future treatment of neurological c onditions6. Glu
neurons are widely distributed in forebrain and h
 ippocampus1. Hippocampus is reported to be largely dependent
upon Glu signalling implicated in learning and memory functions24. Supplements of Glu are available in market
for various purposes such as to maintain blood glucose levels, to increase immunity, to build proteins, and to
promote optimal absorption and a ssimilation27–29. It was initially thought that its systemic or oral administration cannot affect its availability in CNS as Glu cannot cross the B
 BB28,30. But later researchers found that Glu
can cross the BBB up to a certain extent and dietary Glu supplements improve the brain functioning31,32 leading
to generation of hypothesis that chronic free Glu supplementation at a dose equivalent to average daily intake
of humans might have beneficial effect on behaviour of animals. Despite extensive beneficial use in periphery,
studies addressing its beneficial effects on CNS are limited. Since to date studies on the use of free l-Glu on CNS
function are scarce, hence the objective of the present study is therefore specifically to investigate the effects of
free Glu on brain and associated neurobehavioral alterations at a dose equivalent to adequate human intake in
rats. In order to understand the underlying mechanism responsible for behavioural alterations, the current study
was further aimed to monitor the effects of dietary free Glu supplements on motor and cognitive performance
as well as associated changes in brain redox status. Glu/GABA content and monoaminergic and cholinergic
neurotransmission in rats was also studied.

Results

The aim of the current study is to find out the effects of free l-Glu on locomotor activity and learning and
cognitive functioning along with monitoring alterations in oxidative profile and neurochemical content in the
brain as shown in Fig. 1. Along with behavioural the body weight and food intake of rats was also monitored
throughout the experiment. The effects of Glu supplementation on the body weight and food intake were not
different compared to control (Table 1).

Effect of free l‑Glu on locomotor performance. Effect of Glu supplementation on rat’s ambulatory

performance was assessed in OFT in terms of latency to move from the central square and the number of squares
crossings made during 5 min time span which is shown in Fig. 2. Observation showed that ambulatory performance was improved following Glu supplementation compared to controls as evident by significant decline in
latency to move (Fig. 2a) (t (10) = 2.875, P < 0.05) and significant increase in square crossings (t (10) = 11.41,
P < 0.01) during 5 min time span (Fig. 2a) compared to controls.

Scientific Reports |
Vol:.(1234567890)

(2020) 10:11206 |

https://doi.org/10.1038/s41598-020-68041-y

2

www.nature.com/scientificreports/

Food intake

Body weight

Control

Glutamate

Control

Glutamate

Initial

12.65 ± 1.93

11.85 ± 0.82

160.17 ± 10.03

160.11 ± 11.11

Week 1

11.46 ± 0.72

10.84 ± 1.21

163.67 ± 10.98

161.33 ± 11.52

Week 2

10.92 ± 0.67

11.55 ± 1.95

165.05 ± 12.55

163.17 ± 11.28

Week 3

11.41 ± 1.55

11.91 ± 1.68

166.43 ± 12.62

165.83 ± 12.73

Week 4

11.82 ± 1.12

11.90 ± 1.38

168.33 ± 13.03

167.67 ± 13.92

Week 5

10.72 ± 0.75

10.67 ± 0.27

168.67 ± 12.69

169.66 ± 13.62

Table 1.  Effects of dietary free glutamate supplementation on weekly food intake and the body weight of
animals during treatment. Data presented as mean ± SD (n = 6). A non-significant effect was obtained by the
repeated measure analysis when compared with control rats.

Figure 2.  Effect on locomotor activity was evaluated via monitoring (a) ambulatory performance which is
evaluated by open field test in terms of latency (s) to move from the central square (left) the number of squares
crossed (right), (b) muscular strength evaluated by Kondziela’s Inverted screen test in terms of latency (s) to fall
from the inverted screen and (c) motor coordination evaluated by Beam walking test in terms of latency (s) to
cross the beam and number of foot slips off the beam on three different beam sizes (3 cm, 2 cm and 1 cm). For
each group n = 6 and values are presented as mean ± S.D. All significant differences are expressed as * P < 0.05, **
P < 0.01 compared to control group.
Effect of Glu supplementation on muscular strength of rats was evaluated in KIST by recording the latency to
fall from the inverted screen during 2 min time span which is presented in Fig. 2b. It was observed that muscular
strength of rats was increased following Glu supplementation compared to controls as a significant increment
in latency time to fall from inverted screen was observed. Statistical analysis showed a significant (U = P < 0.01)
difference between groups with a mean rank of 9.5 for Glu group compared to controls having mean rank of 3.5.
Effect of Glu supplementation on motor coordination and balance in rats was assessed by beam walking
test by recording latency time taken to cross the beam and number of foot slips off the beam on three different
beam sizes (3 cm, 2 cm and 1 cm) during 2 min time span which is presented in Fig. 2c. It was observed that
motor coordination and balance in rats was increased following Glu treatment compared to controls as evident
by significant reduction in latency time to cross the beam and an increase in score for foot slips off the beam.
There is a significant decline in latency time for beam of 3 cm width (t (10) = 7.278, P < 0.01), for beam of 2 cm
width (t (10) = 8.043, P < 0.01) and for beam of 1 cm width (t (10) = 8.154, P < 0.01) as shown in Fig. 2c. Data
analysis of score for foot slips off the beam revealed that there was no significant difference in score for foot slips
off the beam in Glu supplemented group over beam of 3 cm, 2 cm and 1 cm width comparable to control group.
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◀ Figure 3.  Effect on memory performance is presented; (1) Recognition memory in terms of (a) sniffing time
for familiar (old) and novel object and (b) discrimination index; (2) Spatial memory performance in terms of
(c) escape latencies of acquisition training trials, (d) averaged escape latencies, (e) spatial reference memory
acquisition (1 h probe trial) and (f) retention (24 h probe trial) by monitoring escape latency time, latency
to find the target quadrant (NW), duration of time spent (seconds) in the target quadrant and the number of
entries made by rat over target quadrant; (3) Associative memory performance in terms of (g) step-trough
latency difference. For each group n = 6 and values are presented as mean ± S.D. Significant differences were
expressed as ** P < 0.01 compared to control group and for training trials ** P < 0.01 compared to control
and ++ P < 0.01 compared to trial 1.

Effect of free l‑Glu on learning and memory function. Recognition memory was monitored by ORT
by noting the sniffing time for novel and familiar objects followed by computing discrimination index that is
shown in Fig. 3a and b. Observations showed that recognition memory was improved following Glu supplementation as a significant enhancement was seen in sniffing time for new object and in discrimination index. Statistical analysis showed significant decline (t (10) = 7.022, P < 0.01) in sniffing time for old object following Glu
supplementation in comparison to control group while sniffing time for novel object was significantly increased
(t (10) = 6.896, P < 0.01) in Glu group in comparison to control group as shown in Fig. 3a. Discrimination index
data showed a significant enhancement in (t (10) = 28.01, P < 0.01) Glu group in comparison to controls as shown
in Fig. 3b.
The differences in escape latencies during 4 acquisition trials showed significant effect of trials (F (4,
40) = 287.536, P < 0.01), group (F (1, 10) = 42.04, P < 0.01) and interaction between trials x groups (F (4,
80) = 9.918, P < 0.01). Pair-wise comparisons showed a significant decline over trials in escape latencies of animals which decreased significantly (P < 0.01) (displayed in Fig. 3c) indicating that memory performance was
enhanced in animals over trials. For cumulative escape latency of all acquisition trials a significant increase
was observed in Glu group (t = 6.484, P < 0.01) in comparisons to controls as shown in Fig. 3d. Data analysis
of reference memory parameters during 1 h probe trial showed significant decline in platform latency (escape
latency time to reach platform location) (t (10) = 9.449, P < 0.01) and in target quadrant latency (t (10) = 6.919,
P < 0.01) while significant enhancement in duration of time spent in target quadrant (t (10) = 6.471, P < 0.01) and
in number of entries made over target quadrant (t (10) = 6.755, P < 0.01) as shown in Fig. 3e. Statistical analysis
of reference memory parameters during 24 hr probe trial also revealed significant decline in platform latency (t
(10) = 7.656, P < 0.01) and in target quadrant latency (t (10) = 5.82, P < 0.01), and a significant enhancement in
duration of time spent in target quadrant (t (10) = 9.399, P < 0.01) and in number of entries in target quadrant (t
(10) = 6.874, P < 0.01) in comparison to controls as presented in Fig. 3f.
Associative memory performance was evaluated using PAT by recording step-through latency to enter into
the dark chamber during both training and test phases by evaluating the difference between pre- and post-training step-through latencies presented in Fig. 3g. Observations showed a significant improvement in associative
memory following Glu supplementation as evident by increase in difference between step-through latencies.
Statistical analysis showed a significant increment in difference between step-through latencies of Glu group
during 1 h. (t (10) = 14.106, P < 0.01) and 24 h. (t (10) = 21.1, P < 0.01) sessions in comparison to control group
as presented in Fig. 4. On the basis of results, it can be suggested that following the intake of Glu tablets associative memory was improved.
Effect of chronic administration of free l‑Glu on oxidative status of brain. Effects of Glu sup-

plementation on oxidative status of brain was assessed via estimating the lipid peroxidation (MDA) content,
antioxidant enzyme activities (CAT, GPx and SOD) and content of antioxidant compounds (GSH and protein)
in brain which is presented in Fig. 4. The MDA levels were significantly (t (10) = 6.679, P < 0.01) reduced in Glu
group in comparison to controls as presented in Fig. 4a. Data analysis on content of antioxidant compounds
(GSH and Protein) showed a significant increment in GSH levels (t (10) = 7.144, P < 0.01) and protein content (t
(10) = 14.437, P < 0.01) in Glu group in comparison to controls as presented in Fig. 4b. Moreover, data analysis of
activities of antioxidant enzymes (CAT, GPx and SOD) showed a significant enhancement in activities of CAT (t
(10) = 21.769, P < 0.01), GPx (t (10) = 11.101, P < 0.01) and SOD (t (10) = 4.174, P < 0.01) in Glu group compared
to controls as presented in Fig. 4c. From the findings it can be suggested that following Glu treatment oxidative
status of brain was improved.

Effect of chronic administration of free l‑Glu on neurochemical profile of brain. Cholinergic

status of brain was monitored via estimating ACh content and AChE activity. Results showed enhancement in
ACh content following Glu supplementation. Significant increment (t (10) = 7.73, P < 0.01) in ACh content was
observed in Glu group in comparison to controls as presented in Fig. 5a. While in AchE activity a significant
reduction (t (10) = 14.437, P < 0.01) was seen following Glu supplementation compared to controls as shown in
Fig. 5b.
Effect of Glu supplementation on Glu and GABA levels in hippocampus was also determined. It was observed
that Glu and GABA hippocampal content was altered following Glu treatment as there is a significant increment
in Glu (t (10) = 4.36, P < 0.01) and GABA (t (10) = 6.45, P < 0.01) levels in hippocampus of Glu group compared
to controls as shown in Fig. 5c, d.
Effect of Glu supplementation on monoaminergic profile of brain and hippocampus was determined via estimating the levels of NA, DA, 5-HT and its metabolites (DOPAC, HVA and 5-HIAA) using high pressure liquid
chromatography coupled to electrochemical detection (HPLC-EC) method. It was observed that monoaminergic
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Figure 4.  Effect on oxidative profile of rats was assessed via determining the levels of major oxidant (MDA) (a),
levels of antioxidant (GSH and Protein) compounds (b) and levels of antioxidant enzymes (CAT, GPx, SOD) (c).
For each group n = 6 and values are presented as mean ± S.D. Significant differences were expressed as ** P < 0.01
compared to control group.

profile was altered following Glu treatment. There is a significant increment in NA concentration in brain (t
(10) = 4.84, P < 0.01) and hippocampus (t (10) = 25.823, P < 0.01) of Glu group compared to controls as shown
in Fig. 6a. Regarding DA metabolism there is a significant rise in concentration of DA (t (10) = 3.47, P < 0.01)
and DOPAC (t (10) = 5.96, P < 0.01) in brain following Glu treatment compared to controls while HVA levels
remained comparable. However, in hippocampus significant increase in DA levels (t (10) = 11.87, P < 0.01) and
significant decline in HVA levels (t (10) = 3.72, P < 0.01) was observed following Glu treatment in comparison to
controls whereas no significant change was observed in DOPAC levels as presented in Fig. 6b. 5-HT content was
significantly increased in both brain (t (10) = 12.46, P < 0.01) and hippocampus (t (10) = 6.62, P < 0.01) following
Glu treatment compared to controls while levels of 5-HIAA were significantly (t (10) = 5.73, P < 0.01) decreased
in hippocampus after Glu intake whereas brain 5-HIAA levels remained unaltered as shown in Fig. 6c. Furthermore, the ratios of HVA/DA and 5HIAA/5HT were also computed in brain and hippocampus and a significant
decline was observed in ratio of HVA/DA in both brain (t (10) = 7.87, P < 0.01) and hippocampus (t (10) = 12.24,
P < 0.01) and in the ratio of 5HIAA/5HT in both brain (t (10) = 7.87, P < 0.01) and hippocampus (t (10) = 12.24,
P < 0.01) indicating that monoamine neurotransmission was enhanced following Glu administration.

Discussion

The current study found improvement in motor activity and learning and memory performance following
chronic supplementation of free l-Glu via modulating the neurochemical and redox status in the brain. Reports
showed that intake of l-Glu in drinking water had no effect on food intake and body w
 eight37,38,41. Present
findings support these studies as we also found no significant change in body weight and food intake of rats
which might be associated with high energy expenditure. However present findings contradict with Yin et al.15
who reported increase in growth rate and body weight of pigs following dietary supplementation of 2% Glu for
7 days15. Glu being a major excitatory neurotransmitter is essential for all behaviors21. Our results showed that
locomotor activity was improved following free Glu supplementation. Administration of Glu as a nootropic
agent is a topic of interest since last 60 years. It is evident that Glu has a significant role in cognitive functioning
and Glu signalling in brain contributes in synaptic maintenance and plasticity facilitating cognitive function2,25
and learning1,26. Reports showed that free L-Glu in brain is required for neuronal differentiation, migration
and survival in developing brain by facilitating calcium transport contributing to memory enhancement via
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Figure 5.  Effect on cholinergic and glutamatergic profile of rats was assessed via determining the levels of ACh
content (a) and AChE activity (b) and the levels of hippocampal Glu (c) and GABA (d). For each group n = 6
and values are presented as mean ± S.D. Significant differences were expressed as ** P < 0.01 compared to control
group.
use-dependent alterations in synaptic efficacy that is involved in the formation and function of cytoskeleton42.
But studies regarding the use of Glu as an adjunctive memory-enhancing a gent33 lacks supporting experimental
evidences. Present findings showed that chronic supplementation of free Glu at adequate amount enhances
memory performance leading to improved spatial, recognition and associative memory processes. These findings
are in agreement with the recent study which observed that umami taste in GI is responsible for stimulation of
cortical and sub-cortical brain areas that are linked to working m
 emory40. Moreover, studies showed that the
effect of Glu depends upon its dosage. At low Glu levels intensity of Glu receptor is not high enough to cause
excitotoxicity but indeed sufficient for memory e nhancement33.
Oxidative stress, a state representing enhancement in levels of intracellular reactive oxygen species (ROS)
that either act as free radicals themselves or breakdown to form free radicals43,44. Oxidative stress generation
is attributed to disrupted balance between ROS generation and antioxidant scavenging activity45,46. ROS, the
products of normal cellular metabolism attack PUFAs causing peroxidation of lipids (LPO) and generate MDA
which is an important and sensitive marker of peroxidative damage47. This damage is overcome by the action of
SOD that converts reactive superoxide anions to hydrogen peroxide which then by the action of CAT and GPx
converts into water and molecular oxygen48. Along with these redox enzymes, certain endogenous antioxidants
primarily GSH and proteins also provide defence against ROS via maintaining redox homoeostasis48. Studies
have reported that ingested glutamate is transported to enterocytes via specific Na-dependent transporters and
major amount (75–80%) is metabolized in the intestine by transamination, some amount (5–10%) enters into
blood circulation, while 10–15% is converted to Glutamine and other bioactive molecules of sensory and signaling pathways49,50. Along with this free glutamate is also reported to have an important role in protein stability
as it provides a negative c harge50. Previously it has been observed that Glu addition to culture medium leads to
enhanced cellular proliferation and membrane integrity and protects against oxidative s tress5. A recent report also
validated that Glu has ROS scavenging ability, so it is protective against oxidative stress16. Present findings also
support this notion as we found reduced levels of MDA, the by-product of LPO in the brain of Glu-supplemented
rats showing that it is protective against oxidative stress. Along with reduction in LPO, the GSH and total protein
levels as well as antioxidant enzymes (SOD, CAT and GPx) activities also increased following chronic Glu supplementation. Previous researchers reported that the relationship between Glu and ROS is very complex35,46 as
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Figure 6.  Effect on brain and hippocampal monoaminergic profile of rats was assessed via determining the
levels of monoamines [NA (a), DA (b), 5-HT (c)] and its metabolites [DOPAC (b), HVA (b), 5-HIAA (c)] and
ratio HVA/DA ratio (d) and 5HIAA/5HT (e). For each group n = 6 and values are presented as mean ± S.D.
Significant differences were expressed as ** P < 0.01 compared to control group.
some have reported Glu to be beneficial in ameliorating oxidative stress while others reported it as a neurotoxic
agent. However, current findings are in agreement with the reports that stated beneficial impact of l-Glu supplementation in ameliorating hypoxia-induced oxidative stress via reducing MDA levels and enhancing GSH
levels in rats17, while in pigs it occurs via enhancing SOD levels and GSH content and inhibiting lipid peroxidation and MDA generation15. However, other reports showed that l-Glu supplementation either had no effect on
SOD and CAT l evels1 or failed to alleviate H
 2O2-induced oxidative s tress46 producing oxidative d
 amage35. It had
little effect on increasing SOD and GPx concentration and decreasing MDA content in b
 oars46,51. The antioxidant function of Glu as observed in current study might be due to the fact that it is the major substrate for GSH
synthesis compared to cysteine and glycine15,52,53. GSH homoeostasis is considered to be essential for cellular
defence against oxidative s tress15,52 as it regulates redox state of cell and is involved in detoxification process in
all cell types5,54. It can be depicted from previous reports that reduction in oxidative stress along with improved
neurotransmission might be responsible for enhancement in cognitive retention capacity of animals43. Hence, the
improvement in memory and retention capacity observed in present study might be attributed to the improved
oxidative status of the brain following Glu administration in rats.
Cholinergic neurons play a key role in memory and a ttention32,55 and the neurotransmitter present in these
neurons is acetylcholine (ACh). Evidence showed that both Glu and ACh play important role in memory56 as
interactions between these neurotransmitters may be important for memory formation57. In particular, ACh
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Figure 7.  Schematic representation of findings following chronic supplementation of free Glu in rats.

might be involved in facilitating Glu activity via coordination of acquisition and recall states in cortex and
hippocampus57. Intra-hippocampal infusion of receptor agonist of ACh and Glu also reported to improve retention while infusion of antagonists impaired r etention58. The action of ACh is terminated upon its hydrolysis by
the enzyme AChE thus reducing the availability of ACh in synapse and producing memory d
 eficits59. In current
study we found that supplementation of free Glu reduces the activity of AChE and enhances the ACh content in
brain which might be responsible for improved cognitive performance. Further, we also determined the effect
of Glu supplementation on monoaminergic neurotransmission in brain and found that Glu supplementation
enhances concentration of NA, DA and 5-HT via affecting their metabolism in brain. It has been seen that
HVA/DA (Fig. 6d) and 5HIAA/5HT ratio (Fig. 6e) is reduced following chronic Glu supplementation showing
that turnover of DA and 5HT is reduced and their greater amount is available in synapse for performing their
action which might be responsible for improved locomotor and cognitive function. Previous reports from our
laboratory have shown that increased levels of monoamines (noradrenaline, dopamine and serotonin) paralleled the improvement in cognition and memory function32,60. Moreover, both Glu and GABA levels were
increased following chronic Glu supplementation that may also be responsible for memory improvement in
the present study. These findings contradict the previous studies reporting that Glu behaved as a neurotoxic
agent impairing cognitive performance34, increasing oxidative stress35, damaging neuronal cells and producing
excitotoxic lesions36 ultimately leading to neurodegenerative d
 isorders34,36. However, later on researchers found
free l-Glu as a beneficial agent3,10–12,18,37–39. Although Glu is found abundantly in f oods18, but a brief review of
all the reports regarding beneficial effect of free l-Glu shows that these beneficial effects are only addressed in
periphery while effects on CNS are limited. Moreover, a recent report showed that umami taste (of Glu) activates
para-hippocampal gyrus, an important memory retrieval area, that involves the modulation of working memory
processing and contributes to efficient l earning40.
Thus, it can be concluded that chronic supplementation of free Glu effects the behaviour and brain functioning
of animals via inducing changes in the oxidative and neurochemical systems in brain (see Fig. 7). In addition to
previously reported beneficial effects on periphery, the use of free l-Glu and its beneficial effects in enhancing
neurobiological function highlight the novelty of this work. These beneficial effects may be attributed to the
improvement in redox homoeostasis and neurotransmission in brain. The findings therefore suggest future supplementation of free l-Glu as a useful therapeutic strategy to combat neurological disorders. However, further
targeted studies are needed to elucidate the exact mechanisms behind the efficacy of free l-Glu.

Materials and methods

Animals. Locally bred male Albino-Wistar rats (n = 12) utilised in the study, were purchased from Dow University of Health Sciences, OJHA campus, Karachi, Pakistan. Animals housing and handling conditions were
same as described previously60. Animals were caged individually (to avoid effect of social interaction) with
ad libitum access to cubes of standard rodent diet [A control diet (4.47 kcal/g) containing 25% fat, 50% carbohydrate, and 25% protein] and tap water under a 12:12 h light/dark cycle (lights on at 7:00 am) at controlled room
temperature (22 ± 2 °C). For seven days prior to the experiment, prior to experiments, animals were subjected to
acclimation period and to various handling procedures in order to nullify the psychological affliction of environment for reducing the novelty and handling stress. All animal handling and experimentation were approved by
the institutional ethics and animal care committee of the University of Karachi and were conducted under the
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guidelines of National Institute of Health Guide for the Care and Use of Laboratory A
 nimals61. Balanced design
was followed during all treatment and behavioural assessment to avoid order and time effect.

Drugs. Glutamate (Solgar, USA) tablets (available commercially) used during the study were purchased from

Kousar Medicos. Analytical grade chemicals used in the study were purchased from Sigma Aldrich, USA and
Alfa Aesar, USA. All the reagents for experiments were prepared fresh before starting the experiment. For oral
administration drug solutions were made fresh each day. Tablets were dissolved in distilled water. Controls
received equal volume of distilled water. Glu was administered at the dose of 103 mg/kg body weight32 daily via
oral route for 5 weeks in the volume of 0.2 ml/100 g body weight to each rat. The selection of dose was done
in accordance with the prescription given on the tablets and from this human recommended dose the animal
equivalent dose (AED) was calculated as mentioned by Nair and Jacob,62. The period of experimentation was
5 weeks.

Experimental protocol. Rats (n = 12) (age, 3–4 months, weight, 150–200 g) were divided randomly into
two experimental groups each containing 6 rats (n = 6). Control (Group 1) rats received distilled water daily
while test (Glu) group received aqueous suspension of glutamate tablets at a dose of 103 mg/kg body weight
daily via oral route in a volume of 0.2 ml/150 g body weight to each rat for 5 weeks. At the end of treatment,
the behavioural analysis was conducted as presented in the Fig. 1. Behavioural testing paradigms include; Open
Field test (OFT) for assessing ambulatory activity, Kondziela’s Inverted screen test (KIST) for assessing muscular strength and Beam walking test (BWT) to determine motor co-ordination, Novel Object Recognition test
(NORT) for determining recognition ability, Morris Water Maze test (MWM) and Passive Avoidance task (PAT)
for determining spatial reference and associative memory performance. Subsequent to behavioural analysis, rats
were decapitated to dissect out their brains from the skull as described by Tabassum et al.63. Hippocampus was
also dissected out as described previously60.
Behavioral protocols. Food intake and body weight. Food intake and body weight of rats was monitored
daily during the 5 weeks of the treatment as described previously32 (see details in the supplementary file).

Assessment of locomotor performance. Locomotor performance of rats was assessed by using OFT

to assess ambulatory activity, KIST and BWT to determine muscular strength and motor co-ordination. The
apparatus and procedures used for all these tasks were exactly similar as described earlier63 which is provided in
detail in the supplementary file.

Memory assessment. Memory performance of rats was monitored by using NORT to determine recognition ability, MWM and PAT for assessing the spatial reference and associative memory performance. The apparatus and procedures used for all these tasks were essentially the same as described p
 reviously60. The details of
the procedures are provided in the supplementary file.
Sample collection. For dissecting out the brain rats were decapitated 24 h after the behavioral analysis and

their brains were taken out within 30 s and dipped in ice-cold saline. Thereafter, immediately placed in brain
slicer with ventral side up to dissect out the hippocampus as previously m
 entioned60,63 by inserting the blade at
into the slots of the brain slicer just above and below the hypothalamus, to cut the brain into three slices which
were then shifted to a petri dish placed on ice, moistened with chilled saline (0.9% NaCl). The middle slice was
used to dissect out hippocampus bilaterally with the help of sharp scalpel blade. All the brain and hippocampus
samples were stored at low temperature (− 20 °C) until biochemical (redox and neurochemical) analysis.

Biochemical protocols.

Oxidative status parameters. The tissue homogenate (10%, w/v) was prepared in
phosphate buffer (0.1 M, pH 7.4) followed by centrifugation at 12,000 × g for 20 min at 4 ◦C for estimating the
redox state parameters [lipid peroxidation (LPO) levels, catalase (CAT), glutathione peroxidase (GPx) and superoxide dismutase (SOD) activities, reduced glutathione (GSH) and total protein content] in the same manner
as mentioned by Haider et al.60,64. For further reading refer to the supplementary file.

Neurochemical analysis. Frozen brain samples (20%) were homogenized in extraction medium containing 0.4 M PCA (HClO4; 70%), sodium meta-bisulfate (0.1%), EDTA (0.1%) and cysteine (0.01%) with the help of
an electrical homogenizer using a simple one-step sample preparation method. After homogenization, the samples were placed inside the refrigerator for 15 min to aid the precipitation and then centrifuged at 10,000 rpm for
15 min at 4 °C to precipitate out the protein. The supernatant was collected for determining the GLU, GABA and
monoamine content in brain samples. Thereafter, the content of acetylcholine (ACh), Glu and GABA was estimated in the same manner as determined by Tabassum et al.32 (For details of all protocols see the supplementary
file). The activity of Acetylcholinesterase (AChE) and the concentration of monoamines (NA, DA, 5-HT) and its
metabolites (DOPAC, HVA and 5-HIAA) in the brain and hippocampus was determined as described by Haider
et al.60 (For details of all protocols see the supplementary file). The results were expressed as ng/g of tissue. Along
with this, ratios of HVA/DA and 5-HIAA/5-HT are also presented to determine the turnover rate.
Statistical analysis. The data is presented as mean ± SD and SPSS software version 20.0 was used for the
statistical analysis. The data of the behavioural and neurochemical analysis was analysed by Student’s t-test.
Escape latencies during acquisition trials in MWM were analysed by two-way ANOVA (repeated measures) folScientific Reports |
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lowed by multiple comparisons by Bonferroni’s test. Results of latency score for Kondziela’s inverted screen test
and no of slips during beam walking test was statistically analyzed via Non-parametric (Man-Whitney) analysis.
Statistical differences between experimental groups were determined by two-tailed analysis and the significance
level was set at P ≤ 0.05 for all comparisons.

Ethical approval.

The authors declare that the procedures performed in this study were in accordance with
all applicable international, national, and institutional guidelines for the care and use of animals.

Data availability

Authors will provide data upon request.
Received: 20 July 2019; Accepted: 4 May 2020
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